CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

NovaGo Therapeutics cierra una ronda de financiación para un estudio en lesiones agudas de la médula espinal

Positive
AI Analysis

Summary

NovaGo Therapeutics closed a $30 million Series B funding round led by Neurimmune and Pureos to advance a proof-of-concept study in acute spinal cord injuries.

Clinical Trial Data

Phase

Proof of concept

Importance:5/10
Sentiment:
0.70
financingSeries Bspinal cord injurycapital raise

Read the original article

Published by PR Newswire Pharma on September 2, 2026 10:00 AM

Read Original